| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0264ab149dd139d522f7f14b1a3ea9e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
1998-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aa62903d38712c8008d4f71e65ac54b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_459eb021658ecc83058c623fa795c2c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81b2f11513dc6adb9924bf81c6220822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbeb5687c01b83848bfbcff1d7fce3af |
| publicationDate |
2002-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2191578-C2 |
| titleOfInvention |
Solid pharmaceutical composition containing benzofuran derivatives |
| abstract |
FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to solid pharmaceutical composition for oral administration comprising derivative of benzofuran eliciting anti-arrhythmic activity or one of its pharmaceutically acceptable salts as an active component and pharmaceutically acceptable surface-active substance being possibly in combination with one or more pharmaceutical excipient. Solid pharmaceutical composition for oral administration ensures to maintain solubilization of active component in neutral medium and decrease the degree of its absorption variation into human blood. EFFECT: improved properties of composition. 13 cl, 2 dwg, 13 tbl, 8 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2624857-C1 |
| priorityDate |
1997-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |